Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix immunogenicity study in adults living with HIV
ISRCTN34192276Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Mar 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 4, open-label trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoints: VZV-specific cell-mediated response and VZV-specific antibody response. Started Mar 2024; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ISRCTN34192276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN34192276.